Form 4: Ardelix, Inc. Executive Laura A. Williams Reports Stock Sale to Cover Taxes

Laura A. Williams, Chief Medical Officer of Ardelix, Inc., sold shares of common stock to cover withholding taxes upon the vesting of restricted stock units.

Summary

• On February 20, 2025, Laura A. Williams, the Chief Medical Officer of Ardelix, Inc., sold 4,941 shares of common stock.
• The sale was executed to cover applicable withholding taxes related to the vesting of restricted stock units (RSUs).
• The shares were sold at a weighted average price of $5.623, with individual trades ranging from $5.601611 to $5.625428.
• Following the transaction, Williams directly owns 303,804 shares of Ardelix, Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock sale for tax purposes, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects.

Key Dates

Keywords

Form 4, ARDX, Ardelix, Inc., Laura A. Williams, Stock Sale, Restricted Stock Units, Chief Medical Officer, Beneficial Ownership